Subscribe Sign In Register

Valueact

2017-07-alpha-stephen-taub-value-act-valeant-pharmaceuticals-small.jpg
Premium
Jeffrey Ubben’s ValueAct Continues to Surge Despite its Valeant Stake
Stephen Taub
July 14, 2017
Portfolio
The Morning Brief: Honeywell Investors React to Third Point Stake
Stephen Taub
May 1, 2017
Portfolio
The Morning Brief: Valeant Shares Resume Their Free-Fall
Stephen Taub
April 19, 2017
Portfolio
The Morning Brief: Valeant Pays Officers $130 Million
Amanda Cantrell
March 24, 2017
Portfolio
The Morning Brief: Hedge Funds Gain Seats on Two Boards
Stephen Taub
March 21, 2017
Portfolio
The Morning Brief: Hedge Fund Liquidations Accelerate
Stephen Taub
March 20, 2017
Portfolio
The Morning Brief: ValueAct Buys More Valeant Stock
Stephen Taub
March 17, 2017
Portfolio
The Morning Brief: Investors Trash Valeant’s Stock
Stephen Taub
March 1, 2017
Portfolio
The Morning Brief: Judge Questions Leon Cooperman’s Bid to Have Charges Tossed
Stephen Taub
February 8, 2017
Valeant Pharmaceuticals Offices Ahead Of Earnings Figures
Premium
How ValueAct Shook Off Its Big Loss from Valeant
Stephen Taub
January 6, 2017
Portfolio
The Morning Brief: ESL’s Lampert Gives Sears Another Life Line
Stephen Taub
January 3, 2017
Portfolio
The Morning Brief: Trian’s Peltz Teases Next Big Target
Stephen Taub
December 6, 2016